Der Nervenarzt

, Volume 77, Issue 6, pp 663–670 | Cite as

„Andere Umstände“: Schwangerschaft und immunmodulatorische Therapie bei Multipler Sklerose

  • L. A. Hoffmann
  • T. Kümpfel
  • I. Heer
  • R. Hohlfeld
Übersichten

Zusammenfassung

Familienplanung und Kinderwunsch sind häufig diskutierte Fragen in der MS-Sprechstunde. Offensichtliche Gründe hierfür sind u. a., dass die Erstmanifestation der MS häufig in eine für eine Familiengründung entscheidende Lebensphase fällt. Wie bei anderen chronischen Erkrankungen mit schwierig abschätzbarer Prognose und der Notwendigkeit einer langfristigen medikamentösen Therapie ergeben sich Fragen über mögliche Komplikationen und Konsequenzen der immunmodulatorischen Therapie im Rahmen einer Schwangerschaft. Diese Übersicht soll als Grundlage dienen für die individuelle Beratung und Betreuung MS-betroffener Patientinnen und Patienten, die mit Fragen bezüglich Schwangerschaft und immunmodulatorischer Therapie in die MS-Sprechstunde kommen.

Schlüsselwörter

Multiple Sklerose Schwangerschaft Immunmodulatorische Therapie 

Pregnancy and immunomodulatory therapy in multiple sclerosis patients

Summary

Pregnancy and family planning issues are prominent concerns in the medical care of multiple sclerosis patients, since the disease onset often coincides with a period of life that is decisive in this regard. Multiple sclerosis is a chronic disorder with an unpredictable course and is widely treated with long-term immunomodulatory agents, raising questions regarding the complications and effects of these therapies on pregnancy. This paper gives an overview of the relevant literature and provides a basis for individual counselling of this group of multiple sclerosis patients.

Keywords

Multiple Sclerosis Pregnancy Immunomodulatory treatment 
This is a preview of subscription content, log in to check access.

Notes

Danksagung

Wir danken Sven Jarius für hilfreiche Anmerkungen zum Manuskript.

Interessenkonflikt

Die korrespondierende Autorin versichert, dass keine für diesen Artikel relevanten Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt betreibt, bestehen.

Literatur

  1. 1.
    Abramsky O (1994) Pregnancy and multiple sclerosis. Ann Neurol 36:S38–S41CrossRefPubMedGoogle Scholar
  2. 2.
    Achiron A, Kishner I, Dolev M et al. (2004) Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 251:1133–1137CrossRefPubMedGoogle Scholar
  3. 3.
    Alonso A, Jick SS, Olek MJ et al. (2005) Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62:1362–1365CrossRefPubMedGoogle Scholar
  4. 4.
    Bader AM, Hunt CO, Datta S et al. (1988) Anesthesia for the obstetric patient with multiple sclerosis. J Clin Anesth 1:21–24CrossRefPubMedGoogle Scholar
  5. 5.
    Birk K, Ford C, Smeltzer S et al. (1990) The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 47:738–742PubMedGoogle Scholar
  6. 6.
    Birk K, Rudick R (1986) Pregnancy and multiple sclerosis. Arch Neurol 43:719–726PubMedGoogle Scholar
  7. 7.
    Boskovic R, Wide R, Wolpin J et al. (2005) The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 65:807–811PubMedGoogle Scholar
  8. 8.
    Briggs G, Freeman R (1999) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Williams & Wilkins, BaltimoreGoogle Scholar
  9. 9.
    Confavreux C (2004) Intravenous immunoglobulins, pregnancy and multiple sclerosis. J Neurol 251:1138–1139CrossRefPubMedGoogle Scholar
  10. 10.
    Confavreux C, Hutchinson M, Hours M et al. (1999) [Multiple sclerosis and pregnancy: clinical issues]. Rev Neurol (Paris) 155:186–191Google Scholar
  11. 11.
    Confavreux C, Hutchinson M, Hours MM et al. (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339:285–291CrossRefPubMedGoogle Scholar
  12. 12.
    Coyle PK, Johnson K, Pardo L et al. (2003) Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). Neurology 60(Suppl 1):A60Google Scholar
  13. 13.
    Crawford JS (1983) Epidural analgesia for patients with chronic neurological disease. Anesth Analg 62:621–622PubMedGoogle Scholar
  14. 14.
    Greenberger PA, Odeh YK, Frederiksen MC et al. (1993) Pharmacokinetics of prednisolone transfer to breast milk. Clin Pharmacol Ther 53:324–328PubMedGoogle Scholar
  15. 15.
    Haas J (2000) High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler 6(Suppl 2):S18–S20Google Scholar
  16. 16.
    Haas J, Hommes OR, Bauer M (2005) Multiple Sclerosis: management during pregnancy. GAMPP Study Group, European Charcot Foundation, Octapharma GnmH Poster ECTRIMS 2005Google Scholar
  17. 17.
    Hernan MA, Hohol MJ, Olek MJ et al. (2000) Oral contraceptives and the incidence of multiple sclerosis. Neurology 55:848–854PubMedGoogle Scholar
  18. 18.
    Jones RM, Healy TE (1980) Anaesthesia and demyelinating disease. Anaesthesia 35:879–884PubMedGoogle Scholar
  19. 19.
    Korn-Lubetzki I, Kahana E, Cooper G et al. (1984) Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 16:229–231CrossRefPubMedGoogle Scholar
  20. 20.
    Laplaud DA, LEBPMTWS (2005) Multiple Sclerosis relapse rate increasing after treatment for in-vitro fertilisation. Poster ECTRIMS 2005Google Scholar
  21. 21.
    Mariotti V, Marconi AM, Pardi G (2004) Undesired effects of steroids during pregnancy. J Matern Fetal Neonatal Med 16(Suppl 2):5Google Scholar
  22. 22.
    Millar JH, Allison RS, Cheeseman EA et al. (1959) Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 82:417–426PubMedGoogle Scholar
  23. 23.
    Mueller BA, Zhang J, Critchlow CW (2002) Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol 186:446–452CrossRefPubMedGoogle Scholar
  24. 24.
    Nelson LM, Franklin GM, Jones MC (1988) Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 259:3441–3443CrossRefPubMedGoogle Scholar
  25. 25.
    Orvieto R, Achiron R, Rotstein Z et al. (1999) Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol 82:191–194CrossRefPubMedGoogle Scholar
  26. 26.
    Ostensen M, Villiger PM (2002) Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol 9:155–160CrossRefPubMedGoogle Scholar
  27. 27.
    Park-Wyllie L, Mazzotta P, Pastuszak A et al. (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385–392CrossRefPubMedGoogle Scholar
  28. 28.
    Perlas A, Chan VW (2005) Neuraxial anesthesia and multiple sclerosis. Can J Anaesth 52:454–458PubMedGoogle Scholar
  29. 29.
    Petri M (2003) Immunosuppressive drug use in pregnancy. Autoimmunity 36:51–56CrossRefPubMedGoogle Scholar
  30. 30.
    Pinsky L, Di George AM (1965) Cleft palate in the mouse: a teratogenic index of glucocortocoid potency. Science 147:402–403PubMedGoogle Scholar
  31. 31.
    Poser S, Poser W (1985) Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 18:101CrossRefGoogle Scholar
  32. 32.
    Poser S, Raun NE, Wikstrom J et al. (1979) Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 59:108–118PubMedGoogle Scholar
  33. 33.
    Rieckmann P, Toyka KV, Bassetti C et al. (2004) Escalating immunotherapy of multiple sclerosis—new aspects and practical application. J Neurol 251:1329–1339CrossRefPubMedGoogle Scholar
  34. 34.
    Roullet E, Verdier-Taillefer MH, Amarenco P et al. (1993) Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry 56:1062–1065PubMedGoogle Scholar
  35. 35.
    Saarikoski S,Seppala M (1973) Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 115:1100–1106PubMedGoogle Scholar
  36. 36.
    Sadovnick AD, Eisen K, Hashimoto SA et al. (1994) Pregnancy and multiple sclerosis. A prospective study. Arch Neurol 51:1120–1124PubMedGoogle Scholar
  37. 37.
    Salemi G, Callari G, Gammino M et al. (2004) The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 110:23–26CrossRefPubMedGoogle Scholar
  38. 38.
    Sandberg-Wollheim M, Frank D, Goodwin TM et al. (2005) Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 65:802–806PubMedGoogle Scholar
  39. 39.
    Thompson DS, Nelson LM, Burns A et al. (1986) The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 36:1097–1099PubMedGoogle Scholar
  40. 40.
    Tillmann AJ (1950) The effect of pregnancy on multiple sclerosis and its management. Res Publ Assoc Res Nerv Ment Dis 28:548–582PubMedGoogle Scholar
  41. 41.
    van Walderveen MA, Tas MW, Barkhof F et al. (1994) Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 44:327–329PubMedGoogle Scholar
  42. 42.
    Vukusic S, Hutchinson M, Hours M et al. (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127:1353–1360CrossRefPubMedGoogle Scholar
  43. 43.
    Weinshenker BG, Hader W, Carriere W et al. (1989) The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 39:1438–1440PubMedGoogle Scholar
  44. 44.
    Whitaker JN (1998) Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Engl J Med 339:339–340CrossRefPubMedGoogle Scholar
  45. 45.
    Worthington J, Jones R, Crawford M et al. (1994) Pregnancy and multiple sclerosis—a 3-year prospective study. J Neurol 241:228–233CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2006

Authors and Affiliations

  • L. A. Hoffmann
    • 1
    • 3
  • T. Kümpfel
    • 1
  • I. Heer
    • 2
  • R. Hohlfeld
    • 1
  1. 1.Institut für Klinische NeuroimmunologieKlinikum der Universität München-Großhadern
  2. 2.Klinik und Poliklinik für Frauenheilkunde und GeburtshilfeKlinikum der Universität München-Großhadern
  3. 3.Institut für Klinische NeuroimmunologieKlinikum der Universität München-GroßhadernMünchenDeutschland

Personalised recommendations